News
A New Milestone for e-QuoL: SurPass Goes Live in Croatia
08/07/2026
Children’s Hospital Zagreb introduces the SurPass digital platform, marking a significant milestone in long-term follow-up care for young cancer survivors in Croatia.
e-QuoL project continues to bring innovative digital solutions for long-term follow-up of children, adolescents, and young adult cancer survivors (CAYACS) into routine clinical practice across Europe. At Children’s Hospital Zagreb, Croatia, this vision is now becoming a reality through the implementation of the SurPass digital platform and the enrolment of the first five patients within the framework of e-QuoL!
Dr. Jelena Roganović, late effects specialist and national coordinator for survivorship care implementation, reflected on the professional and personal meaning of this digital transition:
“This is a deeply significant milestone not only for the e-QuoL project but also for CAYACS in Croatia. On a personal level, it is especially meaningful to finally see SurPass implemented in clinical practice after having contributed to its development over many years. Watching it move from an idea and a collaborative effort into routine care for patients is truly rewarding.”
What is SurPass?
SurPass is a digital tool developed within European survivorship care initiatives, including the PanCare network, to support the long-term follow-up of children, adolescents, and young adult cancer survivors (CAYACS). It transforms treatment data into individualized survivorship care plans, including tailored follow-up recommendations, risk-based screening, and structured guidance for lifelong care. It is a class I medical device, implemented within European survivorship care initiatives across six countries (Austria, Belgium, Germany, Italy, Lithuania, and Spain).
“This is also an opportunity to acknowledge and thank the pioneers behind this initiative—Riccardo Haupt, Lars Hjort, and Roderick Skinner, founders of the PanCare network—for their vision and lifelong dedication to improving care for childhood cancer survivors. They have inspired many of us working in survivorship care, myself included, and their contribution deserves sincere recognition,” says Dr. Roganovic.
Building Capacity for the Future of Survivorship Care
Another important aspect to highlight is capacity building within the project. The young project collaborator, Dr. Domagoj Buljan, is working on his PhD thesis on late effects within the framework of the e-QuoL project.
“As a PhD researcher within the e-QuoL project, I am proud to contribute to the establishment of Croatia’s first national cohort of CAYACS, creating a foundation for systematic long-term follow-up and improved survivorship care. I believe that research is most meaningful when it directly improves the lives of patients, and e-QuoL allows me to put that belief into practice,” says Dr. Buljan.
